Sundrug Co Ltd

Common Name

Sundrug

Country

Japan

Sector

Healthcare

Industry

Pharmaceutical Retailers

Employees

7,145

Ticker

9989

Exchange

TOKYO STOCK EXCHANGE

Website

www.sundrug.co.jp

Description

Sundrug Co., Ltd. is a prominent player in Japan's pharmaceutical and retail industry, operating a widespread network of drugstores and dispensing pharmacies. The company primarily focuses on providin... Show more

Financial Statements of Sundrug

Below are the financial statements of Sundrug, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of JPY	2024	2023
Net sales	751,777^a	690,462^a
Cost of sales	-562,457^a	-518,516^a
Gross profit	189,319^a	171,946^a
Selling, general and administrative expenses	—	—
Provision of allowance for doubtful accounts	-17^a	-1^a
Provision for retirement benefits for directors (and other officers)	-11^a	-7^a
Salaries, allowances and bonuses	-54,195^a	-49,681^a
Retirement benefit expenses	-638^a	-638^a
Rent expenses	-31,383^a	-29,590^a
Other	-62,075^a	-54,574^a
Total selling, general and administrative expenses	-148,323^a	-134,493^a
Operating profit	40,996^a	37,452^a
Non-operating income	—	—
Interest income	120^a	119^a
Dividend income	7^a	6^a
Commission income	91^a	74^a
Gain on receipt of donated non-current assets	350^a	254^a
Other	220^a	270^a
Total non-operating income	791^a	725^a
Non-operating expenses	—	—
Interest expenses	-32^a	-36^a
Provision of allowance for doubtful accounts	0^a	-2^a
Other	-26^a	-4^a
Total non-operating expenses	-59^a	-43^a
Ordinary profit	41,728^a	38,134^a
Extraordinary income	—	—
Gain on sale of non-current assets	21^a	157^a
Compensation income	4^a	25^a
State subsidy	429^a	451^a
Other	154^a	26^a
Total extraordinary income	610^a	660^a
Extraordinary losses	—	—
Cancellation penalty	0^a	-123^a
Loss on sale of non-current assets	0^a	-13^a
Loss on retirement of non-current assets	-133^a	-108^a
Loss on cancellation of rental contracts	-9^a	-47^a
Impairment losses	-481^a	-542^a
Loss on tax purpose reduction entry of non-current assets	-242^a	-214^a
Other	-211^a	-35^a
Total extraordinary losses	-1,078^a	-1,084^a
Profit before income taxes	41,261^a	37,710^a
Income taxes - current	-13,130^a	-12,988^a
Income taxes - deferred	-995^a	-980^a
Total income taxes	-12,134^a	-12,007^a
Profit	29,126^a	25,703^a
Profit attributable to non-controlling interests	0^a	0^a
Profit attributable to owners of parent	29,126^a	25,703^a

Verified Sources Behind Sundrug’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sundrug’s data sources below and access millions more through our Disclosure Search.

a. Sundrug's Integrated Report 2024

Trace every data point back to Sundrug’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

b. Sundrug's Integrated Report 2025

Trace every data point back to Sundrug’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Sundrug Co Ltd

Financial Statements of Sundrug

Verified Sources Behind Sundrug’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Sugi Holdings Co Ltd

Cosmos Pharmaceutical Corp

Chugai Pharmaceutical Co Ltd

Shionogi & Co Ltd

Daiichi Sankyo Co Ltd

Astellas Pharma Inc